nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—melanoma	0.682	1	CbGaD
Glipizide—CYP3A4—Temozolomide—melanoma	0.044	0.576	CbGbCtD
Glipizide—CYP3A4—Vemurafenib—melanoma	0.0241	0.316	CbGbCtD
Glipizide—PPARG—dermis—melanoma	0.011	0.235	CbGeAlD
Glipizide—CYP3A4—Docetaxel—melanoma	0.00827	0.108	CbGbCtD
Glipizide—PPARG—leg—melanoma	0.00725	0.155	CbGeAlD
Glipizide—PPARG—hindlimb—melanoma	0.00647	0.139	CbGeAlD
Glipizide—PPARG—appendage—melanoma	0.00555	0.119	CbGeAlD
Glipizide—Retinal haemorrhage—Carmustine—melanoma	0.00352	0.0302	CcSEcCtD
Glipizide—PPARG—endothelium—melanoma	0.00335	0.0718	CbGeAlD
Glipizide—PPARG—blood vessel—melanoma	0.00309	0.0662	CbGeAlD
Glipizide—Traumatic liver injury—Temozolomide—melanoma	0.00298	0.0256	CcSEcCtD
Glipizide—PPARG—neck—melanoma	0.00221	0.0473	CbGeAlD
Glipizide—Eruption—Dactinomycin—melanoma	0.00199	0.0171	CcSEcCtD
Glipizide—Digestion impaired—Temozolomide—melanoma	0.00166	0.0143	CcSEcCtD
Glipizide—PPARG—skin of body—melanoma	0.00143	0.0306	CbGeAlD
Glipizide—Gliclazide—VEGFA—melanoma	0.00139	0.232	CrCbGaD
Glipizide—Chlorpropamide—SLC15A2—melanoma	0.00135	0.225	CrCbGaD
Glipizide—KCNJ11—head—melanoma	0.00133	0.0284	CbGeAlD
Glipizide—Liver injury—Temozolomide—melanoma	0.00132	0.0113	CcSEcCtD
Glipizide—Tolbutamide—SLC15A2—melanoma	0.00132	0.219	CrCbGaD
Glipizide—PPARG—mammalian vulva—melanoma	0.0013	0.0279	CbGeAlD
Glipizide—Foetor hepaticus—Docetaxel—melanoma	0.0013	0.0112	CcSEcCtD
Glipizide—Photosensitivity reaction—Vemurafenib—melanoma	0.00124	0.0107	CcSEcCtD
Glipizide—ABCC8—head—melanoma	0.00122	0.0262	CbGeAlD
Glipizide—Eruption—Docetaxel—melanoma	0.0012	0.0103	CcSEcCtD
Glipizide—Gait disturbance—Carmustine—melanoma	0.00118	0.0101	CcSEcCtD
Glipizide—Aplastic anaemia—Dactinomycin—melanoma	0.00115	0.00989	CcSEcCtD
Glipizide—Gait disturbance—Temozolomide—melanoma	0.00114	0.00976	CcSEcCtD
Glipizide—Liver disorder—Docetaxel—melanoma	0.00108	0.00929	CcSEcCtD
Glipizide—Aplastic anaemia—Temozolomide—melanoma	0.00104	0.00894	CcSEcCtD
Glipizide—Eye disorder—Vemurafenib—melanoma	0.00102	0.00875	CcSEcCtD
Glipizide—Abnormal vision—Carmustine—melanoma	0.001	0.0086	CcSEcCtD
Glipizide—Chills—Vemurafenib—melanoma	0.000978	0.0084	CcSEcCtD
Glipizide—Abnormal vision—Temozolomide—melanoma	0.000968	0.00831	CcSEcCtD
Glipizide—Erythema—Vemurafenib—melanoma	0.000949	0.00815	CcSEcCtD
Glipizide—PPARG—head—melanoma	0.000934	0.02	CbGeAlD
Glipizide—KCNJ11—lymph node—melanoma	0.00093	0.0199	CbGeAlD
Glipizide—Glyburide—SLC15A2—melanoma	0.000912	0.152	CrCbGaD
Glipizide—Thirst—Temozolomide—melanoma	0.000846	0.00727	CcSEcCtD
Glipizide—Hyponatraemia—Carmustine—melanoma	0.000837	0.00719	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000833	0.00716	CcSEcCtD
Glipizide—Diplopia—Carmustine—melanoma	0.000833	0.00716	CcSEcCtD
Glipizide—Arthralgia—Vemurafenib—melanoma	0.000808	0.00694	CcSEcCtD
Glipizide—Myalgia—Vemurafenib—melanoma	0.000808	0.00694	CcSEcCtD
Glipizide—Diplopia—Temozolomide—melanoma	0.000805	0.00692	CcSEcCtD
Glipizide—Pancytopenia—Bleomycin—melanoma	0.000784	0.00673	CcSEcCtD
Glipizide—Hepatocellular injury—Docetaxel—melanoma	0.000738	0.00634	CcSEcCtD
Glipizide—Pancytopenia—Dactinomycin—melanoma	0.000731	0.00628	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000706	0.00606	CcSEcCtD
Glipizide—Pancytopenia—Carmustine—melanoma	0.000684	0.00587	CcSEcCtD
Glipizide—Decreased appetite—Vemurafenib—melanoma	0.000673	0.00578	CcSEcCtD
Glipizide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000669	0.00574	CcSEcCtD
Glipizide—Constipation—Vemurafenib—melanoma	0.000662	0.00569	CcSEcCtD
Glipizide—Pancytopenia—Temozolomide—melanoma	0.000661	0.00568	CcSEcCtD
Glipizide—Hypoaesthesia—Bleomycin—melanoma	0.000657	0.00564	CcSEcCtD
Glipizide—PPARG—lymph node—melanoma	0.000654	0.014	CbGeAlD
Glipizide—Dysuria—Temozolomide—melanoma	0.000651	0.00559	CcSEcCtD
Glipizide—Agranulocytosis—Dactinomycin—melanoma	0.00064	0.0055	CcSEcCtD
Glipizide—Photosensitivity reaction—Temozolomide—melanoma	0.000635	0.00546	CcSEcCtD
Glipizide—Hepatitis—Dactinomycin—melanoma	0.000616	0.00529	CcSEcCtD
Glipizide—Flushing—Bleomycin—melanoma	0.000613	0.00526	CcSEcCtD
Glipizide—Pharyngitis—Dactinomycin—melanoma	0.000611	0.00525	CcSEcCtD
Glipizide—Chills—Bleomycin—melanoma	0.000593	0.00509	CcSEcCtD
Glipizide—Hepatobiliary disease—Temozolomide—melanoma	0.000587	0.00504	CcSEcCtD
Glipizide—Erythema—Bleomycin—melanoma	0.000575	0.00494	CcSEcCtD
Glipizide—Hypoaesthesia—Carmustine—melanoma	0.000574	0.00493	CcSEcCtD
Glipizide—Flushing—Dactinomycin—melanoma	0.000572	0.00491	CcSEcCtD
Glipizide—Hypersensitivity—Vemurafenib—melanoma	0.000571	0.0049	CcSEcCtD
Glipizide—Visual disturbance—Docetaxel—melanoma	0.000565	0.00485	CcSEcCtD
Glipizide—Hepatitis—Temozolomide—melanoma	0.000557	0.00478	CcSEcCtD
Glipizide—Asthenia—Vemurafenib—melanoma	0.000556	0.00477	CcSEcCtD
Glipizide—Visual impairment—Carmustine—melanoma	0.000556	0.00477	CcSEcCtD
Glipizide—Hypoaesthesia—Temozolomide—melanoma	0.000554	0.00476	CcSEcCtD
Glipizide—Pharyngitis—Temozolomide—melanoma	0.000553	0.00475	CcSEcCtD
Glipizide—Chills—Dactinomycin—melanoma	0.000553	0.00475	CcSEcCtD
Glipizide—Pruritus—Vemurafenib—melanoma	0.000548	0.00471	CcSEcCtD
Glipizide—Eye disorder—Carmustine—melanoma	0.000539	0.00463	CcSEcCtD
Glipizide—Hyponatraemia—Docetaxel—melanoma	0.000538	0.00462	CcSEcCtD
Glipizide—Visual impairment—Temozolomide—melanoma	0.000537	0.00461	CcSEcCtD
Glipizide—Erythema—Dactinomycin—melanoma	0.000536	0.0046	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000536	0.0046	CcSEcCtD
Glipizide—Flushing—Carmustine—melanoma	0.000535	0.00459	CcSEcCtD
Glipizide—Ill-defined disorder—Bleomycin—melanoma	0.000534	0.00458	CcSEcCtD
Glipizide—Diarrhoea—Vemurafenib—melanoma	0.00053	0.00455	CcSEcCtD
Glipizide—Migraine—Docetaxel—melanoma	0.000527	0.00453	CcSEcCtD
Glipizide—Eye disorder—Temozolomide—melanoma	0.000521	0.00447	CcSEcCtD
Glipizide—Malaise—Bleomycin—melanoma	0.000519	0.00445	CcSEcCtD
Glipizide—Flushing—Temozolomide—melanoma	0.000517	0.00444	CcSEcCtD
Glipizide—Arrhythmia—Carmustine—melanoma	0.000515	0.00442	CcSEcCtD
Glipizide—Leukopenia—Bleomycin—melanoma	0.000515	0.00442	CcSEcCtD
Glipizide—Dizziness—Vemurafenib—melanoma	0.000512	0.0044	CcSEcCtD
Glipizide—Erythema—Carmustine—melanoma	0.000502	0.00431	CcSEcCtD
Glipizide—Chills—Temozolomide—melanoma	0.0005	0.00429	CcSEcCtD
Glipizide—Ill-defined disorder—Dactinomycin—melanoma	0.000498	0.00427	CcSEcCtD
Glipizide—Vomiting—Vemurafenib—melanoma	0.000492	0.00423	CcSEcCtD
Glipizide—Myalgia—Bleomycin—melanoma	0.00049	0.0042	CcSEcCtD
Glipizide—Abdominal pain upper—Docetaxel—melanoma	0.000489	0.0042	CcSEcCtD
Glipizide—Rash—Vemurafenib—melanoma	0.000488	0.00419	CcSEcCtD
Glipizide—Dermatitis—Vemurafenib—melanoma	0.000488	0.00419	CcSEcCtD
Glipizide—Headache—Vemurafenib—melanoma	0.000485	0.00417	CcSEcCtD
Glipizide—Erythema—Temozolomide—melanoma	0.000485	0.00416	CcSEcCtD
Glipizide—Discomfort—Bleomycin—melanoma	0.000484	0.00415	CcSEcCtD
Glipizide—Malaise—Dactinomycin—melanoma	0.000484	0.00415	CcSEcCtD
Glipizide—Leukopenia—Dactinomycin—melanoma	0.00048	0.00412	CcSEcCtD
Glipizide—Confusional state—Bleomycin—melanoma	0.000473	0.00406	CcSEcCtD
Glipizide—Vision blurred—Carmustine—melanoma	0.000473	0.00406	CcSEcCtD
Glipizide—Tremor—Carmustine—melanoma	0.00047	0.00404	CcSEcCtD
Glipizide—Oedema—Bleomycin—melanoma	0.000469	0.00403	CcSEcCtD
Glipizide—Nausea—Vemurafenib—melanoma	0.00046	0.00395	CcSEcCtD
Glipizide—Thrombocytopenia—Bleomycin—melanoma	0.000459	0.00395	CcSEcCtD
Glipizide—Vision blurred—Temozolomide—melanoma	0.000457	0.00393	CcSEcCtD
Glipizide—Myalgia—Dactinomycin—melanoma	0.000457	0.00392	CcSEcCtD
Glipizide—Tremor—Temozolomide—melanoma	0.000454	0.0039	CcSEcCtD
Glipizide—Discomfort—Dactinomycin—melanoma	0.000451	0.00387	CcSEcCtD
Glipizide—Ill-defined disorder—Temozolomide—melanoma	0.00045	0.00386	CcSEcCtD
Glipizide—Leukopenia—Carmustine—melanoma	0.000449	0.00386	CcSEcCtD
Glipizide—Anorexia—Bleomycin—melanoma	0.000447	0.00384	CcSEcCtD
Glipizide—Pancytopenia—Docetaxel—melanoma	0.00044	0.00377	CcSEcCtD
Glipizide—Oedema—Dactinomycin—melanoma	0.000438	0.00376	CcSEcCtD
Glipizide—Malaise—Temozolomide—melanoma	0.000437	0.00376	CcSEcCtD
Glipizide—Vertigo—Temozolomide—melanoma	0.000436	0.00374	CcSEcCtD
Glipizide—Leukopenia—Temozolomide—melanoma	0.000434	0.00373	CcSEcCtD
Glipizide—Hypertension—Carmustine—melanoma	0.000433	0.00372	CcSEcCtD
Glipizide—Thrombocytopenia—Dactinomycin—melanoma	0.000429	0.00368	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000428	0.00367	CcSEcCtD
Glipizide—Myalgia—Carmustine—melanoma	0.000427	0.00367	CcSEcCtD
Glipizide—Anxiety—Carmustine—melanoma	0.000426	0.00366	CcSEcCtD
Glipizide—Paraesthesia—Bleomycin—melanoma	0.000421	0.00362	CcSEcCtD
Glipizide—Hypertension—Temozolomide—melanoma	0.000419	0.0036	CcSEcCtD
Glipizide—Dyspnoea—Bleomycin—melanoma	0.000418	0.00359	CcSEcCtD
Glipizide—Anorexia—Dactinomycin—melanoma	0.000417	0.00358	CcSEcCtD
Glipizide—Confusional state—Carmustine—melanoma	0.000413	0.00355	CcSEcCtD
Glipizide—Myalgia—Temozolomide—melanoma	0.000413	0.00355	CcSEcCtD
Glipizide—Arthralgia—Temozolomide—melanoma	0.000413	0.00355	CcSEcCtD
Glipizide—Anxiety—Temozolomide—melanoma	0.000412	0.00353	CcSEcCtD
Glipizide—Oedema—Carmustine—melanoma	0.00041	0.00352	CcSEcCtD
Glipizide—Discomfort—Temozolomide—melanoma	0.000408	0.0035	CcSEcCtD
Glipizide—Decreased appetite—Bleomycin—melanoma	0.000408	0.0035	CcSEcCtD
Glipizide—Jaundice—Docetaxel—melanoma	0.000402	0.00345	CcSEcCtD
Glipizide—Pain—Bleomycin—melanoma	0.000401	0.00345	CcSEcCtD
Glipizide—Conjunctivitis—Docetaxel—melanoma	0.000401	0.00345	CcSEcCtD
Glipizide—Thrombocytopenia—Carmustine—melanoma	0.000401	0.00344	CcSEcCtD
Glipizide—Confusional state—Temozolomide—melanoma	0.000399	0.00343	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000399	0.00342	CcSEcCtD
Glipizide—Oedema—Temozolomide—melanoma	0.000396	0.0034	CcSEcCtD
Glipizide—Anorexia—Carmustine—melanoma	0.00039	0.00335	CcSEcCtD
Glipizide—Hepatobiliary disease—Docetaxel—melanoma	0.00039	0.00335	CcSEcCtD
Glipizide—Thrombocytopenia—Temozolomide—melanoma	0.000388	0.00333	CcSEcCtD
Glipizide—Feeling abnormal—Bleomycin—melanoma	0.000387	0.00332	CcSEcCtD
Glipizide—Agranulocytosis—Docetaxel—melanoma	0.000385	0.00331	CcSEcCtD
Glipizide—Hyperhidrosis—Temozolomide—melanoma	0.000383	0.00329	CcSEcCtD
Glipizide—Decreased appetite—Dactinomycin—melanoma	0.00038	0.00327	CcSEcCtD
Glipizide—Anorexia—Temozolomide—melanoma	0.000377	0.00324	CcSEcCtD
Glipizide—Pain—Dactinomycin—melanoma	0.000374	0.00321	CcSEcCtD
Glipizide—Gliclazide—ALB—melanoma	0.000374	0.0622	CrCbGaD
Glipizide—Musculoskeletal discomfort—Carmustine—melanoma	0.000373	0.0032	CcSEcCtD
Glipizide—Urticaria—Bleomycin—melanoma	0.000373	0.0032	CcSEcCtD
Glipizide—Rhinitis—Docetaxel—melanoma	0.000371	0.00319	CcSEcCtD
Glipizide—Hepatitis—Docetaxel—melanoma	0.000371	0.00318	CcSEcCtD
Glipizide—Insomnia—Carmustine—melanoma	0.00037	0.00318	CcSEcCtD
Glipizide—Hypoaesthesia—Docetaxel—melanoma	0.000369	0.00317	CcSEcCtD
Glipizide—Paraesthesia—Carmustine—melanoma	0.000368	0.00316	CcSEcCtD
Glipizide—Pharyngitis—Docetaxel—melanoma	0.000368	0.00316	CcSEcCtD
Glipizide—Dyspnoea—Carmustine—melanoma	0.000365	0.00314	CcSEcCtD
Glipizide—Somnolence—Carmustine—melanoma	0.000364	0.00313	CcSEcCtD
Glipizide—Feeling abnormal—Dactinomycin—melanoma	0.000361	0.0031	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000361	0.0031	CcSEcCtD
Glipizide—Insomnia—Temozolomide—melanoma	0.000358	0.00307	CcSEcCtD
Glipizide—Gastrointestinal pain—Dactinomycin—melanoma	0.000358	0.00307	CcSEcCtD
Glipizide—Visual impairment—Docetaxel—melanoma	0.000357	0.00307	CcSEcCtD
Glipizide—Decreased appetite—Carmustine—melanoma	0.000356	0.00306	CcSEcCtD
Glipizide—Paraesthesia—Temozolomide—melanoma	0.000355	0.00305	CcSEcCtD
Glipizide—Gastrointestinal disorder—Carmustine—melanoma	0.000354	0.00304	CcSEcCtD
Glipizide—Dyspnoea—Temozolomide—melanoma	0.000353	0.00303	CcSEcCtD
Glipizide—Somnolence—Temozolomide—melanoma	0.000352	0.00302	CcSEcCtD
Glipizide—Pain—Carmustine—melanoma	0.00035	0.00301	CcSEcCtD
Glipizide—Constipation—Carmustine—melanoma	0.00035	0.00301	CcSEcCtD
Glipizide—Dyspepsia—Temozolomide—melanoma	0.000348	0.00299	CcSEcCtD
Glipizide—Eye disorder—Docetaxel—melanoma	0.000346	0.00297	CcSEcCtD
Glipizide—Abdominal pain—Dactinomycin—melanoma	0.000346	0.00297	CcSEcCtD
Glipizide—Hypersensitivity—Bleomycin—melanoma	0.000346	0.00297	CcSEcCtD
Glipizide—Decreased appetite—Temozolomide—melanoma	0.000344	0.00295	CcSEcCtD
Glipizide—Flushing—Docetaxel—melanoma	0.000344	0.00295	CcSEcCtD
Glipizide—Gastrointestinal disorder—Temozolomide—melanoma	0.000342	0.00293	CcSEcCtD
Glipizide—Pain—Temozolomide—melanoma	0.000339	0.00291	CcSEcCtD
Glipizide—Constipation—Temozolomide—melanoma	0.000339	0.00291	CcSEcCtD
Glipizide—Feeling abnormal—Carmustine—melanoma	0.000338	0.0029	CcSEcCtD
Glipizide—Asthenia—Bleomycin—melanoma	0.000337	0.00289	CcSEcCtD
Glipizide—Gastrointestinal pain—Carmustine—melanoma	0.000335	0.00288	CcSEcCtD
Glipizide—Chills—Docetaxel—melanoma	0.000332	0.00285	CcSEcCtD
Glipizide—Pruritus—Bleomycin—melanoma	0.000332	0.00285	CcSEcCtD
Glipizide—Arrhythmia—Docetaxel—melanoma	0.000331	0.00284	CcSEcCtD
Glipizide—Feeling abnormal—Temozolomide—melanoma	0.000326	0.0028	CcSEcCtD
Glipizide—Abdominal pain—Carmustine—melanoma	0.000324	0.00278	CcSEcCtD
Glipizide—Gastrointestinal pain—Temozolomide—melanoma	0.000324	0.00278	CcSEcCtD
Glipizide—Erythema—Docetaxel—melanoma	0.000323	0.00277	CcSEcCtD
Glipizide—Hypersensitivity—Dactinomycin—melanoma	0.000322	0.00277	CcSEcCtD
Glipizide—Urticaria—Temozolomide—melanoma	0.000314	0.0027	CcSEcCtD
Glipizide—Asthenia—Dactinomycin—melanoma	0.000314	0.0027	CcSEcCtD
Glipizide—Abdominal pain—Temozolomide—melanoma	0.000313	0.00269	CcSEcCtD
Glipizide—Muscle spasms—Docetaxel—melanoma	0.00031	0.00266	CcSEcCtD
Glipizide—Hypersensitivity—Carmustine—melanoma	0.000302	0.00259	CcSEcCtD
Glipizide—Diarrhoea—Dactinomycin—melanoma	0.000299	0.00257	CcSEcCtD
Glipizide—Vomiting—Bleomycin—melanoma	0.000298	0.00256	CcSEcCtD
Glipizide—Rash—Bleomycin—melanoma	0.000296	0.00254	CcSEcCtD
Glipizide—Dermatitis—Bleomycin—melanoma	0.000296	0.00254	CcSEcCtD
Glipizide—Asthenia—Carmustine—melanoma	0.000294	0.00252	CcSEcCtD
Glipizide—Hypersensitivity—Temozolomide—melanoma	0.000292	0.0025	CcSEcCtD
Glipizide—Syncope—Docetaxel—melanoma	0.000289	0.00248	CcSEcCtD
Glipizide—Leukopenia—Docetaxel—melanoma	0.000289	0.00248	CcSEcCtD
Glipizide—Asthenia—Temozolomide—melanoma	0.000284	0.00244	CcSEcCtD
Glipizide—Loss of consciousness—Docetaxel—melanoma	0.000284	0.00243	CcSEcCtD
Glipizide—Diarrhoea—Carmustine—melanoma	0.00028	0.00241	CcSEcCtD
Glipizide—Pruritus—Temozolomide—melanoma	0.00028	0.0024	CcSEcCtD
Glipizide—Nausea—Bleomycin—melanoma	0.000279	0.00239	CcSEcCtD
Glipizide—Hypertension—Docetaxel—melanoma	0.000278	0.00239	CcSEcCtD
Glipizide—Vomiting—Dactinomycin—melanoma	0.000278	0.00239	CcSEcCtD
Glipizide—Chlorpropamide—ABCB1—melanoma	0.000277	0.0462	CrCbGaD
Glipizide—Rash—Dactinomycin—melanoma	0.000276	0.00237	CcSEcCtD
Glipizide—Arthralgia—Docetaxel—melanoma	0.000275	0.00236	CcSEcCtD
Glipizide—Myalgia—Docetaxel—melanoma	0.000275	0.00236	CcSEcCtD
Glipizide—Dizziness—Carmustine—melanoma	0.000271	0.00233	CcSEcCtD
Glipizide—Diarrhoea—Temozolomide—melanoma	0.000271	0.00233	CcSEcCtD
Glipizide—Confusional state—Docetaxel—melanoma	0.000265	0.00228	CcSEcCtD
Glipizide—Oedema—Docetaxel—melanoma	0.000263	0.00226	CcSEcCtD
Glipizide—Dizziness—Temozolomide—melanoma	0.000262	0.00225	CcSEcCtD
Glipizide—Vomiting—Carmustine—melanoma	0.00026	0.00224	CcSEcCtD
Glipizide—Nausea—Dactinomycin—melanoma	0.00026	0.00223	CcSEcCtD
Glipizide—Shock—Docetaxel—melanoma	0.000259	0.00222	CcSEcCtD
Glipizide—Rash—Carmustine—melanoma	0.000258	0.00222	CcSEcCtD
Glipizide—Dermatitis—Carmustine—melanoma	0.000258	0.00222	CcSEcCtD
Glipizide—Thrombocytopenia—Docetaxel—melanoma	0.000258	0.00221	CcSEcCtD
Glipizide—Headache—Carmustine—melanoma	0.000257	0.0022	CcSEcCtD
Glipizide—Vomiting—Temozolomide—melanoma	0.000252	0.00216	CcSEcCtD
Glipizide—Anorexia—Docetaxel—melanoma	0.000251	0.00215	CcSEcCtD
Glipizide—Rash—Temozolomide—melanoma	0.00025	0.00214	CcSEcCtD
Glipizide—Dermatitis—Temozolomide—melanoma	0.000249	0.00214	CcSEcCtD
Glipizide—Headache—Temozolomide—melanoma	0.000248	0.00213	CcSEcCtD
Glipizide—Nausea—Carmustine—melanoma	0.000243	0.00209	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Docetaxel—melanoma	0.00024	0.00206	CcSEcCtD
Glipizide—Insomnia—Docetaxel—melanoma	0.000238	0.00204	CcSEcCtD
Glipizide—Paraesthesia—Docetaxel—melanoma	0.000236	0.00203	CcSEcCtD
Glipizide—Nausea—Temozolomide—melanoma	0.000235	0.00202	CcSEcCtD
Glipizide—Dyspnoea—Docetaxel—melanoma	0.000235	0.00202	CcSEcCtD
Glipizide—Somnolence—Docetaxel—melanoma	0.000234	0.00201	CcSEcCtD
Glipizide—Dyspepsia—Docetaxel—melanoma	0.000232	0.00199	CcSEcCtD
Glipizide—Decreased appetite—Docetaxel—melanoma	0.000229	0.00196	CcSEcCtD
Glipizide—Gastrointestinal disorder—Docetaxel—melanoma	0.000227	0.00195	CcSEcCtD
Glipizide—Pain—Docetaxel—melanoma	0.000225	0.00193	CcSEcCtD
Glipizide—Constipation—Docetaxel—melanoma	0.000225	0.00193	CcSEcCtD
Glipizide—Feeling abnormal—Docetaxel—melanoma	0.000217	0.00186	CcSEcCtD
Glipizide—Gastrointestinal pain—Docetaxel—melanoma	0.000215	0.00185	CcSEcCtD
Glipizide—Abdominal pain—Docetaxel—melanoma	0.000208	0.00179	CcSEcCtD
Glipizide—Glyburide—ALB—melanoma	0.000196	0.0327	CrCbGaD
Glipizide—Hypersensitivity—Docetaxel—melanoma	0.000194	0.00167	CcSEcCtD
Glipizide—Asthenia—Docetaxel—melanoma	0.000189	0.00162	CcSEcCtD
Glipizide—Glyburide—ABCB1—melanoma	0.000187	0.0312	CrCbGaD
Glipizide—Pruritus—Docetaxel—melanoma	0.000186	0.0016	CcSEcCtD
Glipizide—Diarrhoea—Docetaxel—melanoma	0.00018	0.00155	CcSEcCtD
Glipizide—Dizziness—Docetaxel—melanoma	0.000174	0.00149	CcSEcCtD
Glipizide—Vomiting—Docetaxel—melanoma	0.000167	0.00144	CcSEcCtD
Glipizide—Rash—Docetaxel—melanoma	0.000166	0.00143	CcSEcCtD
Glipizide—Dermatitis—Docetaxel—melanoma	0.000166	0.00142	CcSEcCtD
Glipizide—Headache—Docetaxel—melanoma	0.000165	0.00142	CcSEcCtD
Glipizide—Nausea—Docetaxel—melanoma	0.000156	0.00134	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	7.78e-05	0.00107	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.76e-05	0.00106	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CUBN—melanoma	7.76e-05	0.00106	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SDHD—melanoma	7.73e-05	0.00106	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CSPG4—melanoma	7.73e-05	0.00106	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—BSG—melanoma	7.73e-05	0.00106	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	7.59e-05	0.00104	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—MDM2—melanoma	7.54e-05	0.00103	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CSPG4—melanoma	7.5e-05	0.00103	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SDHD—melanoma	7.5e-05	0.00103	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—BSG—melanoma	7.5e-05	0.00103	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GPAM—melanoma	7.49e-05	0.00103	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—STAT3—melanoma	7.48e-05	0.00103	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP17A1—melanoma	7.45e-05	0.00102	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	7.34e-05	0.00101	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—MDM2—melanoma	7.31e-05	0.001	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLCB4—melanoma	7.31e-05	0.001	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GPAM—melanoma	7.26e-05	0.000995	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—FASN—melanoma	7.18e-05	0.000983	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ABCB1—melanoma	7.14e-05	0.000979	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT3—melanoma	7.04e-05	0.000965	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ITGAV—melanoma	7.04e-05	0.000965	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—RPS3—melanoma	7.01e-05	0.000961	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SNRPE—melanoma	6.9e-05	0.000946	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SKI—melanoma	6.9e-05	0.000946	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIP4K2A—melanoma	6.87e-05	0.000942	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC6A11—melanoma	6.87e-05	0.000942	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTAP—melanoma	6.69e-05	0.000916	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—CDKN2B—melanoma	6.55e-05	0.000898	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.54e-05	0.000896	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—melanoma	6.48e-05	0.000888	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ITGB1—melanoma	6.4e-05	0.000877	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—VDR—melanoma	6.39e-05	0.000876	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLA2G6—melanoma	6.37e-05	0.000872	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1B1—melanoma	6.27e-05	0.000859	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	6.18e-05	0.000847	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLA2G6—melanoma	6.17e-05	0.000846	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LUM—melanoma	5.96e-05	0.000817	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PHGDH—melanoma	5.96e-05	0.000817	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—PTEN—melanoma	5.91e-05	0.000809	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HPSE—melanoma	5.84e-05	0.000801	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CUBN—melanoma	5.74e-05	0.000786	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—VCAN—melanoma	5.72e-05	0.000784	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	5.68e-05	0.000779	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	5.55e-05	0.000761	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ITGB3—melanoma	5.55e-05	0.00076	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—VCAN—melanoma	5.55e-05	0.00076	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SDHD—melanoma	5.54e-05	0.000759	CbGpPWpGaD
Glipizide—PPARG—Metabolism—BSG—melanoma	5.54e-05	0.000759	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CSPG4—melanoma	5.54e-05	0.000759	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAP2K2—melanoma	5.42e-05	0.000743	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NPPA—melanoma	5.4e-05	0.00074	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPAM—melanoma	5.37e-05	0.000735	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IL6—melanoma	5.23e-05	0.000716	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—MAPK1—melanoma	5.15e-05	0.000706	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RAC1—melanoma	5.14e-05	0.000705	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—MAPK1—melanoma	5e-05	0.000685	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP17A1—melanoma	4.91e-05	0.000673	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.84e-05	0.000664	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP17A1—melanoma	4.82e-05	0.000661	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	4.74e-05	0.00065	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH1—melanoma	4.72e-05	0.000647	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KDR—melanoma	4.72e-05	0.000646	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP17A1—melanoma	4.68e-05	0.000641	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MET—melanoma	4.61e-05	0.000632	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CDK4—melanoma	4.61e-05	0.000632	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLA2G6—melanoma	4.56e-05	0.000625	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GNA11—melanoma	4.56e-05	0.000624	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ALB—melanoma	4.47e-05	0.000612	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—FASN—melanoma	4.46e-05	0.000611	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NOTCH1—melanoma	4.44e-05	0.000609	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	4.44e-05	0.000608	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GNA11—melanoma	4.42e-05	0.000605	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC5A5—melanoma	4.39e-05	0.000601	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—FASN—melanoma	4.32e-05	0.000593	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC5A5—melanoma	4.25e-05	0.000583	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GNAQ—melanoma	4.24e-05	0.00058	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CD44—melanoma	4.24e-05	0.00058	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACER3—melanoma	4.18e-05	0.000573	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—HRAS—melanoma	4.14e-05	0.000567	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.13e-05	0.000566	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GNAQ—melanoma	4.11e-05	0.000563	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CD44—melanoma	4.11e-05	0.000563	CbGpPWpGaD
Glipizide—PPARG—Metabolism—VCAN—melanoma	4.1e-05	0.000562	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	4.08e-05	0.000559	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1B1—melanoma	4.06e-05	0.000557	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—melanoma	4.03e-05	0.000552	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—HRAS—melanoma	4.01e-05	0.00055	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HDAC2—melanoma	3.95e-05	0.000541	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1B1—melanoma	3.94e-05	0.00054	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.88e-05	0.000532	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP2—melanoma	3.85e-05	0.000527	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAP2K1—melanoma	3.84e-05	0.000527	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UGT2B10—melanoma	3.82e-05	0.000524	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.77e-05	0.000517	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—melanoma	3.69e-05	0.000506	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—FGF2—melanoma	3.66e-05	0.000501	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HS3ST5—melanoma	3.55e-05	0.000487	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP17A1—melanoma	3.46e-05	0.000474	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.41e-05	0.000467	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ERBB2—melanoma	3.37e-05	0.000462	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—melanoma	3.37e-05	0.000461	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCB1—melanoma	3.34e-05	0.000458	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GNA11—melanoma	3.27e-05	0.000447	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCB1—melanoma	3.24e-05	0.000444	CbGpPWpGaD
Glipizide—PPARG—Metabolism—FASN—melanoma	3.2e-05	0.000438	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CDKN2B—melanoma	3.15e-05	0.000432	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC5A5—melanoma	3.14e-05	0.000431	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PRKCA—melanoma	3.08e-05	0.000422	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—VDR—melanoma	3.08e-05	0.000422	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ERCC2—melanoma	3.05e-05	0.000418	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GNAQ—melanoma	3.04e-05	0.000416	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CD44—melanoma	3.04e-05	0.000416	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PRKCA—melanoma	2.98e-05	0.000409	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.97e-05	0.000407	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ERCC2—melanoma	2.96e-05	0.000406	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CTNNB1—melanoma	2.95e-05	0.000404	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.95e-05	0.000404	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1B1—melanoma	2.91e-05	0.000399	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—melanoma	2.89e-05	0.000396	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NFKB1—melanoma	2.86e-05	0.000392	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.86e-05	0.000392	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PRKCA—melanoma	2.84e-05	0.000389	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ERCC2—melanoma	2.81e-05	0.000386	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACER3—melanoma	2.76e-05	0.000378	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLCB4—melanoma	2.69e-05	0.000369	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	2.64e-05	0.000362	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—melanoma	2.6e-05	0.000356	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—melanoma	2.57e-05	0.000353	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.57e-05	0.000352	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NRAS—melanoma	2.57e-05	0.000352	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—melanoma	2.54e-05	0.000348	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC6A11—melanoma	2.53e-05	0.000347	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIP4K2A—melanoma	2.53e-05	0.000347	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UGT2B10—melanoma	2.52e-05	0.000345	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTAP—melanoma	2.46e-05	0.000337	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK3—melanoma	2.46e-05	0.000337	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—melanoma	2.41e-05	0.00033	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.41e-05	0.00033	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—melanoma	2.4e-05	0.000328	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HS3ST5—melanoma	2.34e-05	0.000321	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK1—melanoma	2.34e-05	0.00032	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—melanoma	2.34e-05	0.00032	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—melanoma	2.34e-05	0.00032	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—melanoma	2.33e-05	0.000319	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH1—melanoma	2.27e-05	0.000311	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—melanoma	2.26e-05	0.000309	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—melanoma	2.23e-05	0.000305	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—melanoma	2.21e-05	0.000303	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PRKCA—melanoma	2.21e-05	0.000302	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LUM—melanoma	2.19e-05	0.000301	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PHGDH—melanoma	2.19e-05	0.000301	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ERCC2—melanoma	2.19e-05	0.0003	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HPSE—melanoma	2.15e-05	0.000295	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—melanoma	2.12e-05	0.00029	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CUBN—melanoma	2.11e-05	0.00029	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—melanoma	2.09e-05	0.000287	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—melanoma	2.06e-05	0.000282	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CSPG4—melanoma	2.04e-05	0.00028	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BSG—melanoma	2.04e-05	0.00028	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SDHD—melanoma	2.04e-05	0.00028	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—melanoma	2.03e-05	0.000278	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPAM—melanoma	1.98e-05	0.000271	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—melanoma	1.88e-05	0.000257	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—melanoma	1.85e-05	0.000253	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—melanoma	1.83e-05	0.000251	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.81e-05	0.000248	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—melanoma	1.8e-05	0.000246	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—melanoma	1.79e-05	0.000245	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCB4—melanoma	1.78e-05	0.000243	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—melanoma	1.77e-05	0.000243	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—melanoma	1.73e-05	0.000237	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G6—melanoma	1.68e-05	0.00023	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC6A11—melanoma	1.67e-05	0.000229	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIP4K2A—melanoma	1.67e-05	0.000229	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—melanoma	1.66e-05	0.000227	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTAP—melanoma	1.62e-05	0.000223	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—melanoma	1.6e-05	0.000219	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—melanoma	1.55e-05	0.000212	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—VCAN—melanoma	1.51e-05	0.000207	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—melanoma	1.5e-05	0.000205	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LUM—melanoma	1.45e-05	0.000198	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PHGDH—melanoma	1.45e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.43e-05	0.000196	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HPSE—melanoma	1.42e-05	0.000195	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CUBN—melanoma	1.39e-05	0.000191	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.38e-05	0.000189	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SDHD—melanoma	1.35e-05	0.000184	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BSG—melanoma	1.35e-05	0.000184	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CSPG4—melanoma	1.35e-05	0.000184	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—melanoma	1.32e-05	0.000181	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPAM—melanoma	1.3e-05	0.000179	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP17A1—melanoma	1.27e-05	0.000175	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK3—melanoma	1.26e-05	0.000172	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.26e-05	0.000172	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.24e-05	0.00017	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—melanoma	1.22e-05	0.000168	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNA11—melanoma	1.2e-05	0.000165	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FASN—melanoma	1.18e-05	0.000161	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC5A5—melanoma	1.16e-05	0.000159	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—melanoma	1.14e-05	0.000157	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—melanoma	1.13e-05	0.000154	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD44—melanoma	1.12e-05	0.000153	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNAQ—melanoma	1.12e-05	0.000153	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G6—melanoma	1.11e-05	0.000152	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.09e-05	0.00015	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—melanoma	1.09e-05	0.00015	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.08e-05	0.000149	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1B1—melanoma	1.07e-05	0.000147	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—VCAN—melanoma	9.95e-06	0.000136	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.46e-06	0.00013	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—melanoma	9.2e-06	0.000126	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—melanoma	8.92e-06	0.000122	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—melanoma	8.83e-06	0.000121	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—melanoma	8.48e-06	0.000116	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP17A1—melanoma	8.4e-06	0.000115	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PRKCA—melanoma	8.12e-06	0.000111	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—melanoma	8.07e-06	0.000111	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ERCC2—melanoma	8.06e-06	0.00011	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNA11—melanoma	7.93e-06	0.000109	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FASN—melanoma	7.76e-06	0.000106	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC5A5—melanoma	7.63e-06	0.000105	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNAQ—melanoma	7.37e-06	0.000101	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD44—melanoma	7.37e-06	0.000101	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1B1—melanoma	7.07e-06	9.69e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.67e-06	9.15e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—melanoma	6.59e-06	9.03e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—melanoma	6.36e-06	8.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—melanoma	6.14e-06	8.42e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCB1—melanoma	5.82e-06	7.98e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—melanoma	5.59e-06	7.66e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—melanoma	5.52e-06	7.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PRKCA—melanoma	5.36e-06	7.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ERCC2—melanoma	5.31e-06	7.28e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—melanoma	4.88e-06	6.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—melanoma	4.83e-06	6.62e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTEN—melanoma	4.21e-06	5.77e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—melanoma	4.2e-06	5.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—melanoma	4.05e-06	5.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—melanoma	3.69e-06	5.06e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—melanoma	3.64e-06	4.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—melanoma	3.22e-06	4.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—melanoma	3.19e-06	4.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—melanoma	2.97e-06	4.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—melanoma	2.78e-06	3.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—melanoma	2.43e-06	3.33e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—melanoma	1.96e-06	2.69e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—melanoma	1.6e-06	2.19e-05	CbGpPWpGaD
